Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
78 participants
INTERVENTIONAL
2024-04-05
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effectiveness of Neurodynamic Mobilization in Carpal Tunnel Syndrome
NCT06882707
Mobilization With Movement in Carpal Tunnel Syndrome.
NCT04733209
Acupuncture for Carpal Tunnel Syndrome
NCT00000394
Effectiveness of Self-Myofascial Stretching on Carpal Tunnel Syndrome
NCT06519058
The Effectiveness of Extracorporeal Shock Wave Therapy for Management of Carpal Tunnel Syndrome
NCT05681663
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment Group
In addition to the exercise given to the control group, the treatment group will receive dry needling in the carpal tunnel area, 2 days a week for 3 weeks, for a total of 5 sessions.
Dry needling
In addition to stretching, nerve mobilization and tendon gliding exercises, a total of 5 sessions of dry needling will be performed for fascial mobilization, 2 days a week for 3 weeks.
Control Group
The control group will be taught and asked to perform stretching, nerve mobilization and tendon-shifting exercises for 3 weeks.
Control group
The physiotherapist will teach stretching, neuromobilization and tendon shifting exercises and will be asked to do them regularly for 3 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dry needling
In addition to stretching, nerve mobilization and tendon gliding exercises, a total of 5 sessions of dry needling will be performed for fascial mobilization, 2 days a week for 3 weeks.
Control group
The physiotherapist will teach stretching, neuromobilization and tendon shifting exercises and will be asked to do them regularly for 3 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Being between the ages of 18-65.
3. Being diagnosed with mild or moderate stage CTS as a result of the electroneurophysiological test.
Exclusion Criteria
2. Having had previous hand surgery.
3. Having an additional acute neck, shoulder, elbow and hand problem.
4. Having a BMI of 40 kg/m2 and above.
5. Being pregnant.
6. As a result of the electroneurophysiological test, the data related to the median nerve are at a severe level.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karabuk University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Musa Güneş
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fidan Yılmaz, MsC
Role: PRINCIPAL_INVESTIGATOR
Pursaklar State Hospital
Emime EMİRMAHMUTOĞLU, Bachelors
Role: PRINCIPAL_INVESTIGATOR
Pursaklar State Hospital
Banu Gökçen BAYDOĞAN TAN, MD
Role: STUDY_DIRECTOR
Pursaklar State Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pursaklar State Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Karabuk-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.